| Literature DB >> 24496643 |
Peter Overath1, Theo Sturm, Hans-Georg Rammensee.
Abstract
Genes of the major histocompatibility complex (MHC), which play a critical role in immune recognition, are considered to influence social behaviors in mice, fish, humans, and other vertebrates via olfactory cues. As studied most extensively in mice, the polymorphism of MHC class I genes is considered to bring about a specific scent signature, which is decoded by the olfactory system resulting in an individual-specific reaction such as mating. On the assumption that this signature resides in volatiles, extensive attempts to identify these MHC-specific components in urine failed. Alternatively, it has been suggested that peptide ligands of MHC class I molecules are released into urine and can elicit an MHC-haplotype-specific behavioral response after uptake into the nose by sniffing. Analysis of the urinary peptide composition of mice shows that MHC-derived peptides are present, albeit in extremely low concentrations. In contrast, urine contains abundant peptides which differ between mouse strains due to genomic variations such as single-nucleotide variations or complex polymorphisms in multigene families as well as in their concentration. Thus, urinary peptides represent a real-time sampling of the expressed genome available for sensory evaluation. It is suggested that peptide variation caused by genomic differences contains sufficient information for individual recognition beyond or instead of an influence of the MHC in mice and other vertebrates.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24496643 PMCID: PMC4055862 DOI: 10.1007/s00018-014-1559-6
Source DB: PubMed Journal: Cell Mol Life Sci ISSN: 1420-682X Impact factor: 9.261
Fig. 1Gas chromatography/mass spectrometry of mouse urinary volatiles. Three chromatograms of aliquots of the same mixture of B6 (black traces) or B6/β2m−/− mice (red traces) are shown. The total ion current is plotted on a logarithmic scale against the retention time. The figure gives an impression of the reproducibility of the tree measurements/sample. There is a nearly complete overlap between the chromatograms of the two samples indicating no qualitative differences. Some components (see for example peak for compound #7) show a small quantitative difference in abundance between the B6 and B6/β2m−/− mice. Numbers below peaks refer to components, which can be looked up in the electronic supplement (Table S1) of Röck et al. [33] (unpublished data of Röck and Overath)
Fig. 2Analysis of peptide and urine-evoked Ca2+ responses in intact VSNs. a Example of somatic Ca2+ recordings from a single VSN to different concentrations of SIINFEKL. A response is defined as a stimulus-dependent deviation in Ca2+ fluorescence that exceeds twice the standard deviation of the mean of the baseline fluorescence noise. b SIINFEKL dose–response curves (grey) each recorded from a single VSN (n = 12 cells, eight slices). Relative changes in peak fluorescence (ΔF/F) induced by a given stimulus were normalized to the maximum peak response measured in a given VSN to construct a dose–response curve. The black curve represents the mean dose–response curve; EC50 value and SD are indicated. c Comparison of Ca2+ responses in a single VSN to various concentrations of SIINFEKL and urine (DU, diluted 100-fold to simulate the decrease in concentration in the VNO duct) obtained from B6/OVA+, B6/OVA+/β2m−/−, and B6 mice. This figure is taken from Sturm et al. [34], where further details can be found. Reprinted by kind permission of Trese Leinders-Zufall
Fig. 3Evolutionary relatedness has a much stronger impact on the urinary peptidome than the MHC. Urinary peptides of five inbred mouse strains were analyzed by mass spectrometry (data from reference [34]), and the normalized Euclidean distances of hundreds of peptide intensities were calculated according to Natsch et al. [62]. The results are depicted as a fraction of the maximal Euclidean distance obtained in the respective experiment. The experiments included BALB/c mice (H2 ) and four strains of the C57 lineage: B10 (H2 ), B10.D2 (H2 ), B6 (H2 ) and B6/β2m−/− (H2 , but lacking functional MHC class I molecules) yielding ten pair-wise comparisons, which are all depicted in both panels (a, b). BALB/c, B6 and B6/β2m−/− mice were each analyzed in two biological replicates yielding two data points for the respective comparisons, which are indicated with colored crosses. These duplicate Euclidean distances were joined to their respective mean value before performing the two-tailed, heteroskedastic Student’s t tests. a The differences in the urinary peptide pattern are independent of the MHC. b Ordering the data depicted in a according to the evolutionary relatedness readily reveals a highly significant difference in the urinary peptidome of BALB/c mice versus the strains of the C57 lineage. A small proportion of this difference is due to SAV peptides and MUP20-specific peptides (see reference [34] for details). However, even when removing the latter two peptide groups from the data set, BALB/c urine clearly separates from C57 urine increasing the p value merely from 0.0017 to 0.0020. Consequently, most of the differences in the urinary peptidome remain unexplained [48]
Genomic variations known or expected to influence the mouse urinary peptidome
| Type of variation (direct effects) | Effect of variation on peptides in urine | Affected proteins | Example for peptide in urine [ | Evidence for peptide in urine [ | ||
|---|---|---|---|---|---|---|
| Standard form (C57BL/6 mice) | Varying form | Standard form | Varying form | |||
| SAV | Exchange of single amino acid at single place | Most, e.g., serine protease inhibitor A3K, further examples in Supplementary Table S8 of reference [ |
|
| Yes | Yes |
| SAV changing posttranslational modification (PTM) | New PTM or loss of PTM at site of SAV | Some, e.g., serine protease inhibitor A3K | PAV | cysteinyl | PAV | Yes | Yes |
| Multiple amino acid variations (highly polymorphic genes) | Exchange of single amino acids at multiple places close to each other | Few, e.g., MUPs |
| Only | Yes | Not yet |
| Insertions and deletions | Peptide containing at least one additional amino acid or lacking at least one amino acid | Few | n.a. | n.a. | Not yet | Not yet |
| New stop codon | C-terminally shortened peptide; absence of certain peptides | Few | n.a. | n.a. | Not yet | Not yet |
| Inactive allele | Absence of certain peptides | Few, e.g., meprin A α (Fig. 5 of reference [ | FQGDILLPR | Peptide missing (C3H/He mice) | Yes | No demonstration of deficiency until now |
| Quantitative differences in expression | Changed concentration | Some, e.g., MUP20 (reference [ | VEYIHVLENSL at high concentration | VEYIHVLENSL at low concentration (BALB/c mice) | Yes | Yes |
| Peptide sequence variation restricted to protease cleavage site | Splitting of peptide into two parts (gain of cleavage site); fusion of two peptides (loss of cleavage site); altered sequence at cleavage site | Some? | n.a. | n.a. | Not yet | Not yet |
This table contains only selected genomic variations known or expected to influence the urinary peptidome without claiming that the list is comprehensive. The capability of VSNs to discriminate single amino acids in peptides is well documented, and length variations of the same core peptide also seem to be recognized by some of these neurons [34, 52]. In contrast, it remains to be tested whether VSNs distinguish between peptides with and without posttranslational modifications (PTMs). n.a. (not available) indicates that an example has not yet been demonstrated experimentally